UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061728
Receipt number R000070581
Scientific Title The efficacy of maxillary nerve block for postoperative pain relief after two-jaw orthognathic surgery: a prospective observational study
Date of disclosure of the study information 2026/06/01
Last modified on 2026/05/29 11:01:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The efficacy of maxillary nerve block for postoperative pain relief after two-jaw orthognathic surgery: a prospective observational study

Acronym

The efficacy of maxillary nerve block for postoperative pain relief after two-jaw orthognathic surgery: a prospective observational study

Scientific Title

The efficacy of maxillary nerve block for postoperative pain relief after two-jaw orthognathic surgery: a prospective observational study

Scientific Title:Acronym

The efficacy of maxillary nerve block for postoperative pain relief after two-jaw orthognathic surgery: a prospective observational study

Region

Japan


Condition

Condition

deformity of jaw

Classification by specialty

Anesthesiology Oral surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To elucidate the efficacy of maxillary nerve block for postoperative pain relief after two-jaw orthognathic surgery

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Pain-intensity score(Visual Analogue Scale: VAS) at 3 hours after the end of anesthetic management and at next morning

Key secondary outcomes

Usage of analgesics, Nausea-intensity score(Visual Analogue Scale: VAS) at 3 hours after the end of anesthetic management and at next morning


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver

Interventions/Control_1

The participants in the intervention group receive maxillary nerve block with 0.5% levobupivacaine or 0.75% ropivacaine 5-8ml before surgery.

Interventions/Control_2

The participants in the control group receive no treatments.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit

50 years-old >=

Gender

Male and Female

Key inclusion criteria

The patients aged 16 to 50 who are scheduled to undergo two-jaw orthognathic surgery by the oral and maxillofacial surgeon in our institution.

Key exclusion criteria

The patients who refuse to participate, have a psychiatric disorder, and contraindicate maxillary nerve block.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name masayuki
Middle name
Last name okada

Organization

Yamagata University Faculty of Medicine

Division name

Department of Anesthesiology

Zip code

990-9585

Address

2-2-2, Iidanishi, Yamagatashi, Yamagata

TEL

023-628-5400

Email

mokada@med.id.yamagata-u.ac.jp


Public contact

Name of contact person

1st name masayuki
Middle name
Last name okada

Organization

Yamagata University Faculty of Medicine

Division name

Department of Anesthesiology

Zip code

990-9585

Address

2-2-2, Iidanishi, Yamagatashi, Yamagata

TEL

023-628-5400

Homepage URL


Email

mokada@med.id.yamagata-u.ac.jp


Sponsor or person

Institute

others

Institute

Department

Personal name

okada masayuki


Funding Source

Organization

self-procurement

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yamagata University Faculty of Medicine Rinsyokenkyukanri center

Address

2-2-2, Iidanishi, Yamagatashi, Yamagata

Tel

023-628-5840

Email

m-suto@med.id.yamagata-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

山形大学医学部附属病院(山形県)


Other administrative information

Date of disclosure of the study information

2026 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2026 Year 03 Month 11 Day

Date of IRB

2026 Year 03 Month 11 Day

Anticipated trial start date

2026 Year 04 Month 01 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 05 Month 29 Day

Last modified on

2026 Year 05 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070581